Denis Chem Lab Peer Comparison

BSE: 537536

₹69.38

₹0.27 (0.39%)

As on 25-Sep-2026IST

Market cap

₹96 Cr

Revenue (TTM)

₹182 Cr

P/E Ratio

12.1

P/B Ratio

1

Div. Yield

3.6 %

Edit

	Denis Chem Lab	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	96	21,555	19,802	18,323	17,490
Revenue (₹ Cr)	182	2,287	1,682	2,570	3,230
Net Profit (₹ Cr)	7.98	678.07	273.51	735.15	666.92
Net Margin (%)	4.32	28.10	16.19	26.88	20.60
RoE (%)	8.90	19.73	11.15	19.16	18.75
Price to Earnings	12.07	32.40	66.60	24.92	27.16
Price-To-Book	1.03	5.87	7.37	4.16	4.34

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Denis Chem Lab	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Operating Revenue	182.44	2,287.33	1,682.47	2,569.77	3,229.67
Total Income	184.51	2,413.29	1,689.83	2,735.39	3,237.12
Total Expenditure	165.78	1,490.75	1,203.91	1,628.14	2,090.06
EBITDA	16.67	796.58	478.55	941.63	1,139.61
Depreciation	6.75	78.10	126.01	57.58	281.06
EBIT	9.91	718.48	352.55	884.05	858.55
Interest	0.76	0.88	52.11	7.69	190.64
Other Income	2.07	125.96	7.37	165.62	7.45
Exceptional Items	0.00	0.00	12.16	-49.16	-17.24
Profit before Tax	11.22	843.56	319.96	992.82	658.12
Provision for Tax	3.24	165.49	46.45	257.67	-8.80
Profit after Tax	7.98	678.07	273.51	735.15	666.92

Liabilities (₹ Cr)

	Denis Chem Lab	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Shareholder's Funds	91.57	3,586.42	2,591.20	4,202.90	3,902.67
Minority Interest	0.00	-12.71	0.00	0.00	-21.81
Non-Current Liabilities	1.59	28.74	266.35	91.50	1,392.75
Current Liabilities	31.67	385.94	848.06	627.48	2,077.10
Total Liabilities	124.83	4,037.51	3,705.61	4,921.88	7,246.72

Assets (₹ Cr)

	Denis Chem Lab	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Non-Current Assets	37.12	1,291.22	2,525.44	770.28	5,617.77
Current Assets	85.34	2,585.66	1,109.77	3,803.22	1,539.85
Total Assets	124.83	4,037.51	3,705.61	4,921.88	7,246.72
Total Debt*	4.18	0.57	657.97	2.50	2,309.68
Net Current Assets	53.68	2,199.72	261.71	3,175.74	-537.25
Contingent Liabilities	19.88	17.53	160.01	370.49	51.57

Cashflow (₹ Cr)

	Denis Chem Lab	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Cash From Operating Activities	4.13	523.24	342.18	967.57	537.99
Cash Flow from Investing Activities	-4.97	-582.30	-325.92	-561.67	-369.46
Cash from Financing Activities	0.44	-46.46	13.62	-798.31	-313.53
Net Cash Inflow / Outflow	-0.39	-105.52	29.88	-392.41	-145.00

Ratios

Profitability Ratios

	Denis Chem Lab	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
ROCE (%)	14.02	24.97	11.43	23.39	14.47
ROE (%)	8.90	19.73	11.15	19.16	18.75
ROA (%)	6.73	18.69	7.80	14.95	9.26
EBIT Margin (%)	5.43	31.41	20.95	34.40	26.58
Net Margin (%)	4.32	28.10	16.19	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Denis Chem Lab	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Revenue Growth (%)	4.06	15.01	27.91	10.69	9.59
EBIT Growth (%)	1.86	18.45	58.32	24.14	16.84
Net Profit Growth (%)	-5.85	19.61	149.56	-9.09	62.68
EPS Growth (%)	-5.85	17.73	-3.57	14.40	67.41
Book Value Growth (%)	7.60	26.75	9.67	-0.34	36.71

Valuation Ratios

	Denis Chem Lab	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Price / Earnings	12.07	32.40	70.65	23.75	26.48
Price / Book Value	1.03	5.87	7.37	4.16	4.34
Dividend Yield (%)	3.60	0.28	0.06	1.87	0.00
EV/EBITDA	4.29	25.80	42.66	16.16	17.32
Market Cap (₹ Cr)	78.47	11,439.22	6,819.66	21,592.90	17,980.08

Solvency Ratios

	Denis Chem Lab	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debt to Equity	0.00	0.00	0.07	0.00	0.24
Short term debt to equity ratio	0.04	0.00	0.16	0.00	0.12
Current Ratio	2.70	6.70	1.31	6.06	0.74
Quick Ratio	2.36	5.59	0.88	5.31	0.53
Interest Coverage	15.69	959.59	7.14	130.11	4.45

Operating Efficiency Ratios

	Denis Chem Lab	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debtors to sales (%)	21.19	36.10	30.84	7.07	21.07
Asset Turnover	1.54	0.63	0.48	0.52	0.45
Receivable days	69.56	121.68	113.81	26.06	63.88
Inventory Days	20.50	63.83	84.76	65.95	43.27
Payable days	80.18	108.28	101.94	81.01	151.85
Cash Conversion Cycle	9.88	77.23	96.62	11.00	-44.70

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly